Colon capsule endoscopy in colorectal cancer screening: Interim analyses of randomized controlled trial CareForColon2015

Abstract

Background and study aims The Danish CareForColon2015 trial, launched in 2020 as part of the Danish Colorectal Cancer Screening program, is the largest randomized controlled trial to date on colon capsule endoscopy (CCE). This paper presents the interim analysis with the objective of ensuring the safety of patients in the intervention group and evaluating the clinical performance of the trial’s predefined clinical parameters.

Patients and methods We evaluated the initial 234 CCEs according to quality, safety, and completion. The participation rates and preference distribution of all individuals invited were analyzed and sample size calculations were adjusted.

Results Fecal immunochemical test and diagnostic participation rates were 62.1 % and 91.1 %, respectively. The completion rate for CCEs was 67.9 % and the rate of conclusive investigations was 80.3 %. The polyp detection rate (PDR) was high (73.5 %), only two (0.85 %) technical failures in 234 videos were observed, and six suspected cancers were identified (2.6 %). No major adverse events were recorded. The required number of invitations had been underestimated due to inaccurate assumptions in sample size calculations.

Conclusions The trial was efficient and safe in terms of CCE quality and time to diagnostic investigation. Participation rates and PDRs were high. The proportion of suspected cancers was lower than expected and will be followed. The completion rate for CCEs was acceptable but lower than expected and the CCE procedure was reviewed for potential improvements and Resolor was added to the regime. The number of invitations for the intervention group of the trial has been adjusted from 62,107 to 185,153.

Publication History

Received: 30 March 2021

Accepted: 22 June 2021

Article published online:
12 November 2021

• References

• 1 Kaalby L, Deding U, Kobaek-Larsen M. et al. Colon capsule endoscopy in colorectal cancer screening: A randomized controlled trial. BMJ Open Gastroenterol 2020; 7: 1-7
• 2 Groth S, Krause H, Behrendt R. et al. Capsule colonoscopy increases uptake of colorectal cancer screening. BMC Gastroenterol 2012; 12: 1-7
• 3 Thygesen MK, Baatrup G, Petersen C. et al. Screening individualsʼ experiences of colonoscopy and colon capsule endoscopy; A mixed methods study. Acta Oncol (Stockholm, Sweden) 2019; 58: 1-6
• 4 Kobaek-Larsen M, Kroijer R, Dyrvig AK. et al. Back-to-back colon capsule endoscopy and optical colonoscopy in colorectal cancer screening individuals. Colorectal Dis 2018; 20: 479-485
• 5 Den tværregionale implementeringsgruppe vedr. tarmkræftscreening. Screenings- og adenomkontrol program for tyk-og endetarmskræft, guidelines for koloskopi og patologi [Screening- and adenomacontrol program for colorectal cancer, guidelines for colonoscopy and pathology]. Danske Regioner; 2014
• 6 Leighton JA, Rex DK. A grading scale to evaluate colon cleansing for the PillCam COLON capsule: A reliability study. Endoscopy 2011; 43: 123-127
• 7 Dansk tarmkræftscreeningsdatabase årsrapport 2018 [Annual Report of the Danish Colorectal Cancer Screening Database 2020]. Database. DCCS; 2020
• 8 Deding U, Henig AS, Salling A. et al. Sociodemographic predictors of participation in colorectal cancer screening. Int J Colorectal Dis 2017; 32: 1117-1124
• 9 Deding U, Henig AS, Hindersson P. et al. Determinants of non-participation in colon examination following positive stool sample in colorectal cancer screening. Eur J Public Health 2019; 29: 1118-1124
• 10 Senore C, Basu P, Anttila A. et al. Performance of colorectal cancer screening in the European Union Member States: Data from the second European screening report. Gut 2019; 68: 1232-1244
• 11 Spada C, Pasha SF, Gross SA. et al. Accuracy of first- and second-generation colon capsules in endoscopic detection of colorectal polyps: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14: 1533-1543
• 12 Deding U, Kaalby L, Bøggild H. et al. Colon capsule endoscopy vs. CT colonography following incomplete colonoscopy: A systematic review with meta-analysis. Cancers (Basel) 2020; 12: 1-17
• 13 Kjølhede T, Ølholm AM, Kaalby L. et al. Diagnostic accuracy of capsule endoscopy compared to colonoscopy for polyp detection: Systematic review and meta-analyses. Endoscopy 2021; 53: 713-721
• 14 Vuik FER, Nieuwenburg SAV, Moen S. et al. Colon capsule endoscopy in colorectal cancer screening: A systematic review. Endoscopy 2021; DOI: 10.1055/a-1308-1297.
• 15 Pioche M, Ganne C, Gincul R. et al. Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: A randomized trial. Endoscopy 2018; 50: 761-769
• 16 Deding U, Herp J, Havshoei AL. et al. Colon capsule endoscopy versus CT colonography after incomplete colonoscopy. Application of artificial intelligence algorithms to identify complete colonic investigations. United Gastroenterol J 2020; 8: 782-789
• 17 Mikkelsen EM, Thomsen MK, Tybjerg J. et al. Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program. Clin Epidemiol 2018; 10: 1649-1655
• 18 Reumkens A, Rondagh EJ, Bakker CM. et al. Post-colonoscopy complications: A systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol 2016; 111: 1092-1101
• 19 Steffenssen MW, Al-Najami I, Zimmermann-Nielsen E. et al. Patient-reported complications related to colonoscopy: A prospective feasibility study of an email-based survey. Acta Oncol 2019; 58: 65-70
• 20 Deding U, Henig AS, Torp-Pedersen C. et al. The effects of reminders for colorectal cancer screening: Participation and inequality. Int J Colorectal Dis 2019; 34: 141-150